Shineco subsidiary reaches large-scale production of high-purity soybean phospholipids
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 10 2025
0mins
Technological Breakthrough: Shineco's subsidiary, Fuzhou Meidashan Biotechnology Co., Ltd., has achieved large-scale production of high-purity soybean phospholipids using its proprietary APCC-UF extraction technology, addressing a significant global technical challenge.
Market Impact and Potential: The product meets leading international standards, suggesting strong commercial potential and the ability to enhance Shineco's business structure, gross margin, and overall valuation, prompting investors to monitor developments in capacity, partnerships, and market access.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
